May 16, 2024 08:39AM
Feb 28, 2024 10:49AM
Feb 8, 2024 09:52AM
Nov 14, 2023 12:52PM
Aug 14, 2023 04:34PM
Jul 18, 2023 08:30AM
Jul 18, 2023 08:30AM BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
May 16, 2023 08:30AM
Apr 3, 2023 08:30AM
Mar 7, 2023 03:13PM
Feb 23, 2023 08:30AM
Jan 27, 2023 08:30AM
Jan 24, 2023 09:00AM
Jan 19, 2023 08:30AM BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use
Dec 7, 2022 09:00AM
Nov 22, 2022 09:01AM
Nov 22, 2022 09:00AM
Nov 15, 2022 09:00AM
Oct 24, 2022 11:30AM
Oct 20, 2022 09:00AM
Oct 13, 2022 08:30AM BioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Sep 6, 2022 08:30AM
Aug 16, 2022 08:30AM
Jul 13, 2022 08:30AM
Jul 6, 2022 09:00AM
Jun 30, 2022 09:00AM
Jun 17, 2022 09:00AM
May 31, 2022 09:00AM BioCorRx to Present at the LD Micro Invitational XII on June 7th
May 19, 2022 08:00AM
May 17, 2022 08:30AM
Apr 27, 2022 08:30AM
Apr 19, 2022 09:01AM
Apr 11, 2022 08:30AM
Apr 1, 2022 08:30AM
Mar 22, 2022 08:30AM BioCorRx to Participate in Two Upcoming Conferences
Mar 16, 2022 09:00AM
Mar 2, 2022 08:30AM
Feb 14, 2022 08:30AM
Jan 5, 2022 09:00AM
Dec 9, 2021 09:00AM
Nov 24, 2021 08:30AM
Nov 22, 2021 09:15AM BioCorRx Acquires Intellectual Property for Drug Delivery
Nov 16, 2021 09:23AM
Nov 10, 2021 02:47PM
Oct 7, 2021 08:30AM
Sep 22, 2021 08:30AM
Sep 8, 2021 07:00AM
Sep 8, 2021 07:00AM
Sep 1, 2021 08:32AM Biocorrx, Inc. (BICX) Awarded $3.5M NIDA Grant for Clinical Trial of BICX104
Sep 1, 2021 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All